VEECO INSTRUMENTS INC
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 25, 2026.
| | | |
|---|---|---|
| | Veeco Instruments Inc. | |
| | | |
| | By: | /s/ WILLIAM J. MILLER, Ph.D. |
| | | William J. Miller, Ph.D. |
| | | Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated, on February 25, 2026.
| Signature | | Title |
|---|---|---|
| | | |
| /s/ WILLIAM J. MILLER, Ph.D. | | Chief Executive Officer and Director |
| William J. Miller, Ph.D. | | (principal executive officer) |
| | | |
| /s/ JOHN P. KIERNAN | | Senior Vice President and Chief Financial Officer |
| John P. Kiernan | | (principal financial & accounting officer) |
| | | |
| /s/ RICHARD A. D’AMORE | | Chairman |
| Richard A. D’Amore | | |
| | | |
| /s/ KATHLEEN A. BAYLESS | | Director |
| Kathleen A. Bayless | | |
| /s/ SUJEET CHAND, Ph.D. Sujeet Chand, Ph.D. | | Director |
| | | |
| /s/ GORDON HUNTER | | Director |
| Gordon Hunter | | |
| | | |
| /s/ KEITH D. JACKSON | | Director |
| Keith D. Jackson | | |
| | | |
| /s/ LENA NICOLAIDES, Ph.D. | | Director |
| Lena Nicolaides, Ph.D. | | |
| | | |
| /s/ MARY JANE RAYMOND | | Director |
| Mary Jane Raymond | | |
| | | |
| /s/ THOMAS ST. DENNIS | | Director |
| Thomas St. Dennis | | |
Index to Consolidated Financial Statements and Financial Statement Schedule
| | Page |
|---|---|
| | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 185) | F-2 |
| Consolidated Balance Sheets at December 31, 2025 and 2024 | F-4 |
| Consolidated Statements of Operations for the years ended December 31, 2025, 2024, and 2023 | F-5 |
| Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2025, 2024, and 2023 | F-6 |
| Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2025, 2024, and 2023 | F-7 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2025, 2024, and 2023 | F-8 |
| Notes to Consolidated Financial Statements | F-9 |
| Schedule II—Valuation and Qualifying Accounts | S-1 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.